Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Vaxcyte, Inc. (PCVX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Eydelman Mikhail (SVP, Gen Counsel & Corp Sec) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 7,992 shares
@ $49.58, valued at
$396.2k
Sold 4,874 shares
@ $50.22, valued at
$244.8k
Sold 7,134 shares
@ $51.44, valued at
$367k
Exercised 20,000 options to buy
@ $21.41, valued at
$428.2k
|
|
| 10/04/2023 |
4
| Wassil Jim (COO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 1,542 shares
@ $49.69, valued at
$76.6k
Sold 608 shares
@ $50.74, valued at
$30.8k
Sold 850 shares
@ $51.56, valued at
$43.8k
Exercised 3,000 options to buy
@ $2.42, valued at
$7.3k
|
|
| 10/04/2023 |
4
| PICKERING GRANT (CEO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 641 shares
@ $49.67, valued at
$31.8k
Sold 385 shares
@ $50.76, valued at
$19.5k
Sold 283 shares
@ $51.52, valued at
$14.6k
Sold 646 shares
@ $49.68, valued at
$32.1k
Sold 221 shares
@ $50.48, valued at
$11.2k
Sold 442 shares
@ $51.55, valued at
$22.8k
|
|
| 09/27/2023 |
4
| PICKERING GRANT (CEO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 15,000 shares
@ $52.4529, valued at
$786.8k
Sold 1,309 shares
@ $52.4243, valued at
$68.6k
Sold 1,309 shares
@ $52.4375, valued at
$68.6k
|
|
| 09/26/2023 |
4
| Wassil Jim (COO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Exercised 3,000 options to buy
@ $2.42, valued at
$7.3k
|
|
| 06/15/2023 |
4
| Lukatch Heath (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $53.08, valued at
$796.2k
|
|
| 06/15/2023 |
4
| Loxam Teri (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $53.08, valued at
$796.2k
|
|
| 06/15/2023 |
4
| Kamarck Michael E. (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $53.08, valued at
$796.2k
|
|
| 06/15/2023 |
4
| Hirth Peter (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $53.08, valued at
$796.2k
|
|
| 06/15/2023 |
4
| Gilbert Halley E (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $53.08, valued at
$796.2k
|
|
| 06/15/2023 |
4
| Drapeau Anne S (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $53.08, valued at
$796.2k
|
|
| 06/15/2023 |
4
| Paya Carlos V (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $53.08, valued at
$796.2k
|
|
| 06/09/2023 |
4
| Eydelman Mikhail (SVP, Gen Counsel & Corp Sec) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Paid exercise price by delivering 645 shares
@ $51.25, valued at
$33.1k
|
|
| 01/12/2023 |
4
| Lukatch Heath (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 233 shares
@ $46.0413, valued at
$10.7k
Sold 82 shares
@ $46.3274, valued at
$3.8k
Exercised 315 options to buy
@ $16, valued at
$5k
|
|
| 01/04/2023 |
4
| Fairman Jeff (VP, Research) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 15,000 options to buy
@ $47.95, valued at
$719.3k
|
|
| 01/04/2023 |
4
| Dhaliwal Harpreet S. (SVP Cml Mfg & Supply Chain) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 15,000 options to buy
@ $47.95, valued at
$719.3k
|
|
| 01/04/2023 |
4
| Sauer Paul (SVP Process Dev, Manufacturing) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 15,000 options to buy
@ $47.95, valued at
$719.3k
|
|
| 01/04/2023 |
4
| Eydelman Mikhail (SVP, Gen Counsel & Corp Sec) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 27,500 options to buy
@ $47.95, valued at
$1.3M
|
|
| 01/04/2023 |
4
| Wassil Jim (COO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 42,000 options to buy
@ $47.95, valued at
$2M
|
|
| 01/04/2023 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 42,000 options to buy
@ $47.95, valued at
$2M
Exercised 23,691 options to buy
@ $5.35, valued at
$126.7k
|
|
| 01/04/2023 |
4
| PICKERING GRANT (CEO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 108,250 options to buy
@ $47.95, valued at
$5.2M
Exercised 15,158 options to buy
@ $2.03, valued at
$30.8k
|
|
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2022 |
4
| Fairman Jeff (VP, Research) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 5,000 shares
@ $25.5, valued at
$127.5k
|
|
| 09/28/2022 |
4
| PICKERING GRANT (CEO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 4,773 shares
@ $24.687, valued at
$117.8k
Sold 227 shares
@ $25.299, valued at
$5.7k
Sold 4,681 shares
@ $24.676, valued at
$115.5k
Sold 319 shares
@ $25.281, valued at
$8.1k
|
|
| 09/21/2022 |
4
| Wassil Jim (COO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 2,680 shares
@ $26.091, valued at
$69.9k
Sold 120 shares
@ $26.56, valued at
$3.2k
Exercised 2,800 options to buy
@ $2.42, valued at
$6.8k
|
|
| 09/21/2022 |
4
| GUGGENHIME ANDREW (President and CFO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 2,623 shares
@ $26.019, valued at
$68.2k
Sold 477 shares
@ $26.52, valued at
$12.7k
Exercised 3,100 options to buy
@ $5.35, valued at
$16.6k
|
|
| 09/19/2022 |
4
| PICKERING GRANT (CEO) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 11,000 shares
@ $27.9466, valued at
$307.4k
|
|
| 09/07/2022 |
4
| Fairman Jeff (VP, Research) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Paid exercise price by delivering 519 shares
@ $26.38, valued at
$13.7k
Sold 4,664 shares
@ $26.5381, valued at
$123.8k
Sold 336 shares
@ $27.1382, valued at
$9.1k
|
|
|
|
|